Yeda

1 stories about Yeda
מכון ויצמן רחובות

Korea's BioLeaders To Invest $10 Million in Weizmann Institute Anti-Cancer Therapy

21.03.19|Adi Pick
BioLeaders has agreed to commit $10 million towards a company being spun off of Yeda Research and Development, Weizmann’s technology transfer arm
ProfilesEngineServlet?at=39&mi=10&pt=18&dpi=1243103233&pai=cTech&dpn=4409&mt=1